Total raised
—
Stage
Pre-Funding
Founded
2016
Headcount
1-10
HQ
Caesarea
Sector
Health Tech & Life Sciences
About
RadSense is developing a device for applying pressure to the radial artery in order to prevent bleeding while still allowing blood flow through the radial artery.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is RadSense's primary product development?
- RadSense is developing a device designed to apply pressure to the radial artery to prevent bleeding while maintaining blood flow through the artery.
- When was RadSense founded?
- RadSense was founded in May 2016.
- What is the current operational status of RadSense?
- RadSense is currently inactive and ceased operations in May 2022.
- What is RadSense's primary sector classification?
- RadSense's primary sector is Health Tech & Life Sciences, specifically focusing on Medical Devices and Medical Treatment & Therapeutics.
- Where is RadSense headquartered?
- RadSense is headquartered in Caesarea, Israel, at Tarshish Street 5.
- Who are the founders of RadSense?
- The founders of RadSense are Ran Kornowski and Roni Talic.
- What is RadSense's current funding stage?
- RadSense is in the Pre-Funding stage, with a total raised amount of $0 USD.
- What is the product stage of RadSense's device?
- RadSense's product is in the clinical trial stage.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 Patents
Tags
medical-devicessurgeonssurgerycardiovascular